Introduction to Pain Pathways and Mechanisms
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
NS201C Anatomy 1: Sensory and Motor Systems
NS201C Anatomy 1: Sensory and Motor Systems 25th January 2017 Peter Ohara Department of Anatomy [email protected] The Subdivisions and Components of the Central Nervous System Axes and Anatomical Planes of Sections of the Human and Rat Brain Development of the neural tube 1 Dorsal and ventral cell groups Dermatomes and myotomes Neural crest derivatives: 1 Neural crest derivatives: 2 Development of the neural tube 2 Timing of development of the neural tube and its derivatives Timing of development of the neural tube and its derivatives Gestational Crown-rump Structure(s) age (Weeks) length (mm) 3 3 cerebral vesicles 4 4 Optic cup, otic placode (future internal ear) 5 6 cerebral vesicles, cranial nerve nuclei 6 12 Cranial and cervical flexures, rhombic lips (future cerebellum) 7 17 Thalamus, hypothalamus, internal capsule, basal ganglia Hippocampus, fornix, olfactory bulb, longitudinal fissure that 8 30 separates the hemispheres 10 53 First callosal fibers cross the midline, early cerebellum 12 80 Major expansion of the cerebral cortex 16 134 Olfactory connections established 20 185 Gyral and sulcul patterns of the cerebral cortex established Clinical case A 68 year old woman with hypertension and diabetes develops abrupt onset numbness and tingling on the right half of the face and head and the entire right hemitrunk, right arm and right leg. She does not experience any weakness or incoordination. Physical Examination: Vitals: T 37.0° C; BP 168/87; P 86; RR 16 Cardiovascular, pulmonary, and abdominal exam are within normal limits. Neurological Examination: Mental Status: Alert and oriented x 3, 3/3 recall in 3 minutes, language fluent. -
Antidepressants for Functional Gastrointestinal Disorders
Antidepressants for the treatment of Functional Gastrointestinal Disorders Commonly IBS, constipation, diarrhea, functional abdominal pain and esophageal hypersensitivity Document adapted from literature available from the UNC Center for Functional GI & Motility Disorders What are Functional Gastrointestinal Disorders (FGIDs)? There are many different FGIDs (over 20), but among them, IBS is the most common. FGIDs are characterized by abnormal changes in the movement of muscles throughout the intestines (motility abnormality), an increase in the sensations produced by digestive tract activity (visceral hypersensitivity), and brain-gut dysfunction, especially in the brain’s ability to regulate painful signals from the GI tract. People with IBS have an increased awareness and interpretation of these activities as being abnormal. Motility Abnormality Visceral Hypersensitivity Brain-Gut Dysfunction Instead of normal muscular People with IBS, and other When nerve impulses from the gut reach activity (motility) during digestion, FGIDs, may experience an the brain, they may be experienced as people with IBS may experience increased sensitivity in the more severe or less severe based on the painful spasms and cramping. If nerves of the GI tract. This can regulatory activity of the brain-gut axis. motility is too fast it may produce happen after a GI infection or Signals of pain or discomfort travel from diarrhea and if it is too slow it operation which causes injury the intestines back to the brain. The may result in constipation. Motility to the nerves. This produces a brain usually has the ability to “turn abnormalities may be associated lower pain threshold for normal down” the pain by sending signals that with: cramping, belching, digestive sensations, leading to block nerve impulses produced in the GI urgency, and abdominal pain and discomfort. -
Managing Cancer Pain
The British Pain Society's Managing cancer pain - information for patients From the British Pain Society, supported by the Association of Palliative Medicine and the Royal College of General Practitioners January 2010 To be reviewed January 2013 2 Cancer Pain Management Published by: The British Pain Society 3rd floor Churchill House 35 Red Lion Square London WC1R 4SG Website: www.britishpainsociety.org ISBN: 978-0-9551546-8-3 © The British Pain Society 2010 Information for Patients 3 Contents Page What can be done for people with cancer pain 4 Understanding cancer pain 4 Knowing what to expect 6 Options for pain control – most pain can be controlled 6 Coping with cancer pain 8 Describing pain – communicating with your doctors 9 Talking to others with cancer pain 12 Finding help managing cancer pain 12 References 12 Methods 12 Competing Interests 13 Membership of the group and expert contributors 13 4 Cancer Pain Management What can be done for people with cancer pain? There are medicines and expertise available that can help to control cancer pain. However, surveys show that cancer pain is still poorly controlled in many cases. As a result, patients must know what is available, what they have a right to and how to ask for it. Cancer itself and the treatments for cancer, including both medicines and surgery, can cause pain. Treatments can be directed either at the cause of the pain (for example, the tumour itself) or at the pain itself. Understanding cancer pain Cancer pain can be complicated, involving pain arising from inflammation (swelling), nerve damage and tissue damage from many sites around the body. -
Review of Spinal Cord Basics of Neuroanatomy Brain Meninges
Review of Spinal Cord with Basics of Neuroanatomy Brain Meninges Prof. D.H. Pauža Parts of Nervous System Review of Spinal Cord with Basics of Neuroanatomy Brain Meninges Prof. D.H. Pauža Neurons and Neuroglia Neuron Human brain contains per 1011-12 (trillions) neurons Body (soma) Perikaryon Nissl substance or Tigroid Dendrites Axon Myelin Terminals Synapses Neuronal types Unipolar, pseudounipolar, bipolar, multipolar Afferent (sensory, centripetal) Efferent (motor, centrifugal, effector) Associate (interneurons) Synapse Presynaptic membrane Postsynaptic membrane, receptors Synaptic cleft Synaptic vesicles, neuromediator Mitochondria In human brain – neurons 1011 (100 trillions) Synapses – 1015 (quadrillions) Neuromediators •Acetylcholine •Noradrenaline •Serotonin •GABA •Endorphin •Encephalin •P substance •Neuronal nitric oxide Adrenergic nerve ending. There are many 50-nm-diameter vesicles (arrow) with dark, electron-dense cores containing norepinephrine. x40,000. Cell Types of Neuroglia Astrocytes - Oligodendrocytes – Ependimocytes - Microglia Astrocytes – a part of hemoencephalic barrier Oligodendrocytes Ependimocytes and microglial cells Microglia represent the endogenous brain defense and immune system, which is responsible for CNS protection against various types of pathogenic factors. After invading the CNS, microglial precursors disseminate relatively homogeneously throughout the neural tissue and acquire a specific phenotype, which clearly distinguish them from their precursors, the blood-derived monocytes. The ´resting´ microglia -
Evoked Spinal Cord Potentials.Pdf
EVPPR 11/29/05 12:39 PM Page I K. Shimoji, W.D. Willis, Jr. (Eds.) Evoked Spinal Cord Potentials An Illustrated Guide to Physiology, Pharmacology, and Recording Techniques EVPPR 11/29/05 12:39 PM Page III K. Shimoji, W.D. Willis, Jr. (Eds.) Evoked Spinal Cord Potentials An Illustrated Guide to Physiology, Pharmacology, and Recording Techniques With 130 Figures EVPPR 11/30/05 10:06 AM Page IV Editors: Koki Shimoji, M.D., Ph.D., FRCA Professor, Frontier University Ube Graduate School of Human Sciences 2-1-1 Bunkyodai, Ube, Yamaguchi 755-0805,Japan Professor Emeritus, Niigata University Visiting Professor, Saitama Medical College William D. Willis, Jr., M.D., Ph.D. Professor of Neuroscience and Cell Biology University of Texas Medical Branch 301 University Blvd., Galveston, TX 77555-1069, USA Authors: Tatsuhiko Kano, M.D., Ph.D. Professor and Chairman Department of Anesthesiology Kurume University School of Medicine Yoichi Katayama, M.D., Ph.D. Professor and Chairman Department of Neurosurgery Nihon University School of Medicine Satoru Fukuda, M.D., Ph.D. Professor and Chairman Department of Anesthesiology and Reanimation Fukui University School of Medicine Library of Congress Control Number: 2005935847 ISBN-10 4-431-24026-8 Springer-Verlag Tokyo Berlin Heidelberg New York ISBN-13 978-4-431-24026-6 Springer-Verlag Tokyo Berlin Heidelberg New York This work is subject to copyright. All rights are reserved, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broad- casting, reproduction on microfilms or in other ways, and storage in data banks. -
Correlation of Diffusion Tensor Imaging Indices with Histological
Marquette University e-Publications@Marquette Master's Theses (2009 -) Dissertations, Theses, and Professional Projects Correlation of Diffusion Tensor Imaging Indices with Histological Parameters in Rat Cervical Spinal Cord Gray Matter Following Distal Contusion Spinal Cord Injury Robin Easow Mottackel Marquette University Recommended Citation Mottackel, Robin Easow, "Correlation of Diffusion Tensor Imaging Indices with Histological Parameters in Rat Cervical Spinal Cord Gray Matter Following Distal Contusion Spinal Cord Injury" (2010). Master's Theses (2009 -). Paper 69. http://epublications.marquette.edu/theses_open/69 CORRELATION OF DIFFUSION TENSOR IMAGING INDICES WITH HISTOLOGICAL PARAMETERS IN RAT CERVICAL SPINAL CORD GRAY MATTER FOLLOWING DISTAL CONTUSION SPINAL CORD INJURY By Robin E. Mottackel, B.E. A Thesis submitted to the Faculty of the Graduate School, Marquette University, in Partial Fulfillment of the Requirements for the Degree of Master of Science Milwaukee, Wisconsin December 2010 ABSTRACT CORRELATION OF DIFFUSION TENSOR IMAGING INDICES WITH HISTOLOGICAL PARAMETERS IN RAT CERVICAL SPINAL CORD GRAY MATTER FOLLOWING DISTAL CONTUSION SPINAL CORD INJURY Robin E. Mottackel, B.E. Marquette University, 2010 The purpose of this study was to delineate the diffusion tensor imaging (DTI) parameters across the cervical spinal cord gray matter (GM) in a distal (T8) rat contusion spinal cord injury (SCI) model. DTI data were obtained from ex vivo rat spinal cords and registered to corresponding histological slices in samples from the acute through chronic stages of SCI including uninjured control, 2 weeks post injury, 15 weeks post injury and 25 weeks post injury groups (n = 5 in all groups). After imaging, samples were dehydrated, blocked in paraffin, sliced axially and stained with eriochrome cyanine R stain and H&E counter-stain. -
Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gutlbrain Interaction): a Rome Foundation Working Team Report Douglas A
Gastroenterology 2018;154:1140–1171 SPECIAL REPORT Neuromodulators for Functional Gastrointestinal Disorders (Disorders of GutLBrain Interaction): A Rome Foundation Working Team Report Douglas A. Drossman,1,2 Jan Tack,3 Alexander C. Ford,4,5 Eva Szigethy,6 Hans Törnblom,7 and Lukas Van Oudenhove8 1Center for Functional Gastrointestinal and Motility Disorders, University of North Carolina, Chapel Hill, North Carolina; 2Center for Education and Practice of Biopsychosocial Care and Drossman Gastroenterology, Chapel Hill, North Carolina; 3Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium; 4Leeds Institute of Biomedical and Clinical Sciences, University of Leeds, Leeds, United Kingdom; 5Leeds Gastroenterology Institute, St James’s University Hospital, Leeds, United Kingdom; 6Departments of Psychiatry and Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania; 7Departments of Internal Medicine and Clinical Nutrition, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; and 8Laboratory for BrainÀGut Axis Studies, Translational Research Center for Gastrointestinal Disorders, University of Leuven, Leuven, Belgium BACKGROUND & AIMS: Central neuromodulators (antide- summary information and guidelines for the use of central pressants, antipsychotics, and other central nervous neuromodulators in the treatment of chronic gastrointestinal systemÀtargeted medications) are increasingly used for treat- symptoms and FGIDs. Further studies are needed to confirm ment -
Descending Influences on Vestibulospinal and Vestibulosympathetic Reflexes
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Frontiers - Publisher Connector REVIEW published: 27 March 2017 doi: 10.3389/fneur.2017.00112 Descending influences on Vestibulospinal and Vestibulosympathetic Reflexes Andrew A. McCall, Derek M. Miller and Bill J. Yates* Department of Otolaryngology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA This review considers the integration of vestibular and other signals by the central ner- vous system pathways that participate in balance control and blood pressure regulation, with an emphasis on how this integration may modify posture-related responses in accordance with behavioral context. Two pathways convey vestibular signals to limb motoneurons: the lateral vestibulospinal tract and reticulospinal projections. Both path- ways receive direct inputs from the cerebral cortex and cerebellum, and also integrate vestibular, spinal, and other inputs. Decerebration in animals or strokes that interrupt corticobulbar projections in humans alter the gain of vestibulospinal reflexes and the responses of vestibular nucleus neurons to particular stimuli. This evidence shows that supratentorial regions modify the activity of the vestibular system, but the functional importance of descending influences on vestibulospinal reflexes acting on the limbs Edited by: is currently unknown. It is often overlooked that the vestibulospinal and reticulospinal Bernard Cohen, Icahn School of Medicine at systems mainly terminate on spinal interneurons, and not directly on motoneurons, yet Mount Sinai, USA little is known about the transformation of vestibular signals that occurs in the spinal Reviewed by: cord. Unexpected changes in body position that elicit vestibulospinal reflexes can also William Michael King, produce vestibulosympathetic responses that serve to maintain stable blood pressure. -
Abdominal Visceral Pain: Clinical Aspect*
Rev Dor. São Paulo, 2013 out-dez;14(4):311-4 ARTIGO DE REVISÃO Abdominal visceral pain: clinical aspects* Dor visceral abdominal: aspectos clínicos Telma Mariotto Zakka1, Manoel Jacobsen Teixeira1, Lin Tchia Yeng1 *Recebido do Centro Interdisciplinar de Dor do Hospital de Clínicas da Faculdade de Medicina / Universidade de São Paulo. São Paulo, SP, Brasil. ABSTRACT CONTEÚDO: Como as doenças viscerais podem determinar dores de vários tipos e, habitualmente, desafiam os médicos no seu diagnós- BACKGROUND AND OBJECTIVES: Abdomen is the most fre- tico e tratamento, os autores descreveram de forma prática, as carac- quent site for acute or chronic painful syndromes, for referred pain terísticas dolorosas e as associações com as doenças mais incidentes. from distant structures or for pain caused by systemic injuries. Ab- CONCLUSÃO: O tratamento interdisciplinar com a associação das dominal visceral pain is induced by hollow viscera or parenchymal medidas farmacológicas aos procedimentos de medicina física e rea- viscera walls stretching or by peritoneal stretching. Complex diag- bilitação e ao acompanhamento psicológico diminui o sofrimento e nosis and treatment have motivated this study. Patients with chronic as incapacidades e melhora a qualidade de vida. abdominal pain are usually undertreated and underdiagnosed. The Descritores: Dor abdominal, Dor miofascial, Dor visceral, Trata- interdisciplinary treatment aims at minimizing patients’ distress, re- mento interdisciplinar. lieving pain and improving their quality of life. CONTENTS: Since visceral diseases may determine pain of different INTRODUÇÃO types and, usually, challenge physicians with regard to their diagnosis and treatment, the authors have described in a practical way painful A dor visceral pode decorrer por tensão ou estiramento da parede characteristics and associations with more common diseases. -
Clinical Evidence on Visceral Pain. Systematic Review Evidência Clínica Sobre Dor Visceral
Rev Dor. São Paulo, 2017 jan-mar;18(1):65-71 REVIEW ARTICLE Clinical evidence on visceral pain. Systematic review Evidência clínica sobre dor visceral. Revisão sistemática Durval Campos Kraychete1, José Tadeu Tesseroli de Siqueira2, João Batista Garcia3, Rioko Kimiko Sakata4, Ângela Maria Sousa5, Daniel Ciampi de Andrade6, Telma Regina Mariotto Zakka7, Manoel Jacobsen Teixeira7 and Diretoria da Sociedade Brasileira para o Estudo da Dor de 2015 DOI 10.5935/1806-0013.20170014 ABSTRACT RESUMO BACKGROUND AND OBJECTIVES: Visceral pain is in- JUSTIFICATIVA E OBJETIVOS: A dor visceral é causada por duced by abnormalities of organs such as stomach, kidneys, anormalidades de órgãos como o estômago, rim, bexiga, vesícula bladder, gallbladder, intestines and others and includes disten- biliar, intestinos ou outros e inclui distensão, isquemia, inflama- sion, ischemia, inflammation and mesenteric traction. It is re- ção e tração do mesentério. É responsável por incapacidade física sponsible for physical and psychic incapacity, absenteeism and e psíquica, absenteísmo do trabalho e má qualidade de vida. O poor quality of life. This study aimed at discussing major aspects objetivo deste estudo foi discutir os principais aspectos da dor of visceral pain with regard to prevalence, etiology and diagnosis. visceral relacionados a prevalência, etiologia e diagnóstico. CONTENTS: According to Evidence-Based Medicine concepts, CONTEÚDO: Foram revisados segundo os preceitos da Medic- visceral pain etiology, diagnosis and prognosis were reviewed in ina Baseada em Evidência os enfoques etiológicos, diagnóstico LILACS, EMBASE and Pubmed databases. Therapeutic stud- e prognóstico da dor visceral nas bases de indexações biomédi- ies were not selected. The following terms were used as search cas, LILACS, EMBASE e Pubmed. -
AAV-Based Gene Therapy for Axonal Regeneration in a Rat Model of Rubrospinal Tract Lesion
AAV-based gene therapy for axonal regeneration in a rat model of rubrospinal tract lesion Dissertation For the award of the degree “Doctor of Philosophy” Division of Mathematics and Natural Sciences of the Georg-August-Universität-Göttingen, Germany Submitted by Malleswari Challagundla Born in Kothaganeshunipadu (India) Göttingen, February 2014 Thesis committee members Prof. Dr. Mathias Bähr Prof. Dr. André Fischer Prof. Dr. Wolfgang Brück Extended thesis committee members Prof. Dr. Tiago Fleming Outeiro Dr. Camin Dean Prof. Dr. Ralf Heinrich 2 Declaration I hereby declare that the thesis “AAV-based gene therapy for axonal regeneration in a rat model of rubrospinal tract lesion” has been written independently with no other sources and aids otherwise quoted. Malleswari Challagundla, Göttingen, February 2014. 3 TABLE OF CONTENTS Declaration 3 TABLE OF CONTENTS 4 1 Introduction 7 1.1 Spinal cord injury 7 1.1.1 Spinal cord anatomy 7 1.1.2 Corticospinal and rubrospinal tracts 8 1.1.3 Spinal cord lesion and pathophysiology 10 1.2 Axonal regeneration and plasticity after SCI 12 1.3 Barriers of axonal regeneration in the CNS 13 1.3.1 Myelin inhibitors 13 1.3.2 Scar tissue 13 1.4 Current treatment approaches for SCI 14 1.5 Anti-scarring treatment (BPY-DCA) 16 1.6 Gene therapy 16 1.6.1 Rho and Rho kinase (ROCK) 17 1.6.2 BAG1 20 1.6.3 microRNA-134 21 1.6.4 Reggie1 22 1.7 Aims of the thesis 23 2 Materials 24 2.1 Instruments 24 2.2 Chemicals and Consumables 25 2.3 Solutions and Buffers 26 2.3.1 Mowiol 26 2.3.2 Paraformaldehyde (PFA) 4% 26 2.3.3 1x -
Milnacipran, a Serotonin and Norepinephrine Reuptake Inhibitor: a Novel Treatment for Fibromyalgia
Drug Evaluation Milnacipran, a serotonin and norepinephrine reuptake inhibitor: a novel treatment for fibromyalgia Milnacipran hydrochloride is a serotonin (5-HT) and norepinephrine (NE) reuptake inhibitor that was recently approved by the US FDA for the treatment of fibromyalgia (FM). Evidence has accumulated suggesting that, in animal models, milnacipran may exert pain-mitigating influences involving norepinephrine- and serotonin-related processes at supraspinal, spinal and peripheral levels in pain transmission. Milnacipran has demonstrated efficacy for the reduction of pain as well as improvements in global assessments of well-being and functional capacity among treated FM patients. Its role in addressing comorbidities associated with FM, including visceral pain and migraine, has, as yet, to be investigated. Milnacipran may be of special interest for use in patients for whom hepatic dysfunction precludes the use of other agents, for example, duloxetine. It has a negligible influence on cytochrome metabolism, and therefore may be of particular benefit in patients requiring multiple concurrently prescribed medications. Milnacipran may comprise a reasonable option in the armamentarium of treatments available to manage FM. KEYWORDS: antidepressants n chronic pain n fibromyalgian milnacipran n serotonin Raphael J Leo and norepinephrine reuptake inhibitor Department of Psychiatry, School of Medicine and Fibromyalgia (FM) is a syndrome characterized Several pharmacological approaches have Biomedical Sciences, by chronic, widespread musculoskeletal pain and been advocated for the treatment of FM. State University of New York at tenderness. The prevalence of FM in the general Because of their impact on these presump- Buffalo, Erie County Medical population is estimated to be 2–4%; it tends to tive pathophysiologic processes, antidepres- Center, 462 Grider Street, show a female predilection, and increases with sants have frequently been advocated for Buffalo, NY 14215, USA age [1,2].